mechlorethamine has been researched along with Lymphomatoid Papulosis in 4 studies
nitrogen mustard : Compounds having two beta-haloalkyl groups bound to a nitrogen atom, as in (X-CH2-CH2)2NR.
Lymphomatoid Papulosis: Clinically benign, histologically malignant, recurrent cutaneous T-cell lymphoproliferative disorder characterized by an infiltration of large atypical cells surrounded by inflammatory cells. The atypical cells resemble REED-STERNBERG CELLS of HODGKIN DISEASE or the malignant cells of CUTANEOUS T-CELL LYMPHOMA. In some cases, lymphomatoid papulosis progresses to lymphomatous conditions including MYCOSIS FUNGOIDES; HODGKIN DISEASE; CUTANEOUS T-CELL LYMPHOMA; or ANAPLASTIC LARGE-CELL LYMPHOMA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To study the exact frequency and the histological features of cutaneous intolerance to mechlorethamine (CIM) hydrochloride therapy in patients with cutaneous T-cell lymphomas, including Langerhans cell histiocytosis." | 7.70 | A prospective study of cutaneous intolerance to topical mechlorethamine therapy in patients with cutaneous T-cell lymphomas. French Study Group of Cutaneous Lymphomas. ( Avril, MF; Bagot, M; Beylot-Barry, M; Delaunay, M; Estève, E; Grange, F; Joly, P; Laroche, L; Souteyrand, P; Thomine, E; Vaillant, L; Wechsler, J, 1999) |
| "To study the exact frequency and the histological features of cutaneous intolerance to mechlorethamine (CIM) hydrochloride therapy in patients with cutaneous T-cell lymphomas, including Langerhans cell histiocytosis." | 3.70 | A prospective study of cutaneous intolerance to topical mechlorethamine therapy in patients with cutaneous T-cell lymphomas. French Study Group of Cutaneous Lymphomas. ( Avril, MF; Bagot, M; Beylot-Barry, M; Delaunay, M; Estève, E; Grange, F; Joly, P; Laroche, L; Souteyrand, P; Thomine, E; Vaillant, L; Wechsler, J, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Trager, MH | 1 |
| Chen, C | 1 |
| Husain, S | 1 |
| Geskin, LJ | 1 |
| Shang, SX | 1 |
| Chen, H | 1 |
| Sun, JF | 1 |
| Xu, XL | 1 |
| Koeppel, MC | 1 |
| Horschowski, N | 1 |
| Terrier, G | 1 |
| Andrac, L | 1 |
| Stoppa, AM | 1 |
| Signoret, R | 1 |
| Sayag, J | 1 |
| Estève, E | 1 |
| Bagot, M | 1 |
| Joly, P | 1 |
| Souteyrand, P | 1 |
| Beylot-Barry, M | 1 |
| Vaillant, L | 1 |
| Delaunay, M | 1 |
| Avril, MF | 1 |
| Laroche, L | 1 |
| Grange, F | 1 |
| Thomine, E | 1 |
| Wechsler, J | 1 |
1 review available for mechlorethamine and Lymphomatoid Papulosis
| Article | Year |
|---|---|
Lymphomatoid papulosis and Hodgkin's disease: report of a case.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin D | 1994 |
3 other studies available for mechlorethamine and Lymphomatoid Papulosis
| Article | Year |
|---|---|
Nitrogen mustard gel-induced inflammation triggers lymphomatoid papulosis in patients with mycosis fungoides.
Topics: Administration, Cutaneous; Adult; Aged; Antineoplastic Agents, Alkylating; Female; Gels; Humans; Ki- | 2020 |
Regional lymphomatoid papulosis successfully controlled by interferon α-2b and nitrogen mustard solution.
Topics: Female; Humans; Interferon alpha-2; Interferon-alpha; Lymphomatoid Papulosis; Mechlorethamine; Middl | 2013 |
A prospective study of cutaneous intolerance to topical mechlorethamine therapy in patients with cutaneous T-cell lymphomas. French Study Group of Cutaneous Lymphomas.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkyla | 1999 |